Table 4.
Pituitary hormones and Rigiscan measurements before and after treatment.
| Baseline | After treatment | P value | |
|---|---|---|---|
| Random GHa (μg/L) | 12.63 [3.64-35.45] | 0.44 [0.20-4.00] | 0.001** |
| GHn(μg/L) | 12.26 [3.14-27.05] | 0.09 [0.04-2.37] | 0.001** |
| IGF-1b index | 2.63 ± 0.92 | 1.42 ± 0.88 | 0.000** |
| Total testosterone(nmol/L) | 6.34 ± 4.26 | 9.71 ± 4.62 | 0.000** |
| FSHc(IU/L) | 7.55 ± 6.54 | 7.58 ± 4.84 | 0.954 |
| LHd(IU/L) | 4.51 ± 3.45 | 5.32 ± 3.25 | 0.081 |
| PRLe(ng/mL) | 17.60 [8.57-83.71] | 6.88 [5.02-10.53] | 0.028* |
| Free cortisone (μg/dl) | 10.59 ± 5.26 | 9.46 ± 3.80 | 0.418 |
| TSHf (mIU/L) | 0.955 [0.550-2.065] | 1.350 [0.838-1.558] | 0.898 |
| FT4 g (pmol/L) | 16.32 ± 3.51 | 17.87 ± 3.09 | 0.020* |
| Rigiscan measurements | |||
| Duration of tip rigidity>60% (min) | 13.50 [5.25-19.25] | 16.50 [3.75-22.5] | 0.283 |
| Number of erections (per night) | 6.16 ± 3.65 | 6.16 ± 3.21 | 1.000 |
| Erection duration (min) | 73.50 [48.75-113.5] | 77.50 [48.38-93.25] | 0.957 |
| Average tip rigidity (%) | 41.76 ± 18.59 | 48.48 ± 16.01 | 0.194 |
| Change of tip tumescence (%) | 28.40 ± 13.28 | 34.76 ± 13.35 | 0.101 |
| Average base rigidity (%) | 41.12 ± 12.29 | 41.48 ± 9.57 | 0.893 |
| Change of base tumescence (%) | 40.80 ± 11.35 | 44.56 ± 7.21 | 0.119 |
GHa, growth hormone; IGF-1b, insulin like growth factor-1; FSHc, follicle-stimulating hormone; LHd, luteinizing hormone; PRLe, prolactin; TSHf, thyroid-stimulating hormone; FT4 g, free thyroxine; P* < 0.05, P** < 0.01.